2017 MDA Scientific Conference - Overview
The 2017 MDA Scientific Conference will bring together influential professionals in the academic, government, industrial and clinical arenas who work in various ways to help drive scientific and therapeutic advancements and discoveries. The conference will focus on better understanding disease causes, identifying new therapeutic targets and innovative technologies and discussing new advances in preclinical and clinical research — all aimed at accelerating drug development and targeted treatments for neuromuscular diseases.
Early-Bird Registration Date: Feb. 10, 2017
Registration Deadline: Feb. 28, 2017
Conference presentations and discussions will focus on the following areas:
- Genetics, epigenetics and gene discovery
- Approaches to precision medicine
- Understanding nuclear membranes and protein misfolding/turnover
- Gaining insights into channelopathies, dystrophin glycocomplex diseases, mitochondrial myopathies, repeat expansion diseases
- Motor and peripheral neuron diseases, and
- Clinical trials
Nearly 450 leaders in the neuromuscular field are expected to gather for this prestigious conference to share critical updates on a wide range of scientific topics. The conference facilitates multiple opportunities for the exchange of ideas and dialogue, and includes two evening poster sessions.
